Novel AOMs, largely based around incretin therapy, may exceed weight loss of 20% [10, 75], however, most trials evaluating their efficacy and safety were performed with younger adults, and those that include older adults often poorly define the number of participants in each age group
Molecules such as fibroblast growth factor 21 (47), BCL2 interacting protein 3/NIP3-like protein X (48) and acteoside (via the NRF2-mitophagy axis) (49) mitigate ferroptosis by restoring mitochondrial function or removing damaged mitochondria, underscoring the protective role of mitophagy against ferroptosis
Injectable BPC-157 Standard dose range: 200500 mcg per day Administration: Subcutaneous injection, once daily or split into two doses Cycle length: Typically 412 weeks, followed by an assessment period Injection site: Abdominal subcutaneous tissue
Study Credentials This report summarises PCR Corp independent clinical study ABUSUP1M, conducted at PCR Corp Manchester between December 2023 and March 2024